Home › Overweight › Pennsylvania › Philadelphia

Pag-aaral pangklinika para sa Overweight sa Philadelphia, PA

14 pag-aaral para sa Overweight ang naghahanap ng mga kalahok sa mga site sa loob at paligid ng Philadelphia (sa loob ng humigit-kumulang 30 milya). Buksan ang pag-aaral upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

Nagre-recruitPhase 3

Abington Medical Specialists, Horsham · 16 mi ang layo
Family Practice Associates, Wilmington · 25 mi ang layo

Edad 45 hanggang 99 · Lahat ng kasarian · Na-update Okt 5, 2026 · NCT07037433

A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity

Nagre-recruitPhase 3

Clinical Renal Associates Ltd., Media · 12 mi ang layo
Suburban Research Associates, West Chester · 24 mi ang layo

Edad 18 pataas · Lahat ng kasarian · Na-update Set 28, 2026 · NCT07794579

Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight

Nagre-recruitPhase 3

Thomas Jefferson University - Medicine/GI and Hepatology, Philadelphia

Edad 18 hanggang 70 · Lahat ng kasarian · Na-update Set 24, 2026 · NCT06937099

Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study

Nagre-recruitPhase 3

Thomas Jefferson University - Medicine/GI and Hepatology, Philadelphia

Edad 18 hanggang 70 · Lahat ng kasarian · Na-update Set 24, 2026 · NCT06937086

Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight

Nagre-recruitPhase 3

Keystone Clinical Studies, Plymouth Meeting · 12 mi ang layo

Edad 18 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT07353931

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes

Nagre-recruitPhase 3

AURORA-2 Clinical Site, Philadelphia

Edad 18 pataas · Lahat ng kasarian · Na-update Set 16, 2026 · NCT07743450

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities

Nagre-recruitPhase 3

AURORA-1 Clinical Site, Philadelphia

Edad 18 pataas · Lahat ng kasarian · Na-update Set 16, 2026 · NCT07743463

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes

Nagre-recruitPhase 3

Suburban Research Associates - West Chester Office, West Chester · 24 mi ang layo

Edad 18 pataas · Lahat ng kasarian · Na-update Set 14, 2026 · NCT07351045

A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)

Nagre-recruitPhase 3Malugod na tinatanggap ang malusog na boluntaryo

ACCOMPLISH-2 Research Site, Philadelphia

Edad 18 hanggang 79 · Lahat ng kasarian · Na-update Set 11, 2026 · NCT07654374

Research Study on How Well Oral Semaglutide Works for Weight Loss in Adults With Excess Body Weight

Nagre-recruitPhase 3

UPA Ctr Weight and Eating Dis, Philadelphia

Edad 18 pataas · Lahat ng kasarian · Na-update Set 9, 2026 · NCT07770841

A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)

Nagre-recruitPhase 4

Dermatology Associates of Plymouth Meeting, Plymouth Meeting · 12 mi ang layo

Edad 18 pataas · Lahat ng kasarian · Na-update Set 4, 2026 · NCT06857942

A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus

Nagre-recruitPhase 3

Research Site, Philadelphia

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 25, 2026 · NCT07784725

Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)

Nagre-recruitPhase 3

ACCOMPLISH-1 Research Site, Philadelphia

Edad 18 hanggang 79 · Lahat ng kasarian · Na-update Ago 10, 2026 · NCT07654361

An Acceptance-Based Healthy Lifestyle Intervention for Diverse Adolescents

Nagre-recruitMalugod na tinatanggap ang malusog na boluntaryo

Drexel University, Philadelphia

Edad 14 hanggang 19 · Kababaihan · Na-update Hul 20, 2026 · NCT06147973

Pag-aaral para sa Overweight sa ibang lungsod

Iba pang pag-aaral sa Philadelphia

Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.